Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America

2025-03-17 – Press Releases – www.prnewswire.com

MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the Brazilian Health Regulatory Agency (Agencia Nacional de Vigilancia Sanitaria or ‘ANVISA’) has approved Illuccix®…

Read the full article here.